Cargando…

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines

Antiphospholipid antibody syndrome (APS) requires long-term anticoagulation to prevent recurrent thrombosis. Direct oral anticoagulants (DOACs) have been increasingly used in APS patients, but contradictory guidelines recommendations on their use do exist. We performed a systematic review of literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Menichelli, Danilo, Cammisotto, Vittoria, Pignatelli, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368436/ https://www.ncbi.nlm.nih.gov/pubmed/34414220 http://dx.doi.org/10.3389/fcvm.2021.715878

Ejemplares similares

Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study
por: Pastori, Daniele, et al.
Publicado: (2021)

Multiple Arterial Thrombosis in Seronegative Antiphospholipid Syndrome: Need for New Diagnostic Criteria?
por: Pastori, Daniele, et al.
Publicado: (2019)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
por: Pastori, Daniele, et al.
Publicado: (2017)

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
por: Tuttolomondo, Antonino, et al.
Publicado: (2023)

Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome
por: Rachwan, Rayan Jo, et al.
Publicado: (2017)

Emergency Cardiac Surgery in Patients on Direct Oral Anticoagulants
por: De Paulis, Stefano, et al.
Publicado: (2022)

The impact of direct oral anticoagulants on viscoelastic testing – A systematic review
por: Sahli, Sebastian D., et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis
por: Gullapalli, Keerthi, et al.
Publicado: (2022)

Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Nocella, Cristina, et al.
Publicado: (2021)

Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report
por: Menichelli, Danilo, et al.
Publicado: (2023)

Comparison of medication adherence to different oral anticoagulants: population-based cohort study
por: Ingason, Arnar B, et al.
Publicado: (2023)

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
por: Violi, Francesco, et al.
Publicado: (2015)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
por: Pastori, Daniele, et al.
Publicado: (2018)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: A systematic review and meta-analysis
por: Bakr, Lubna, et al.
Publicado: (2023)

Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome
por: Killian, Martin, et al.
Publicado: (2022)

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Bitar, Yasmin de Souza Lima, et al.
Publicado: (2021)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis
por: Tsai, Sung Huang Laurent, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Elfar, Sohil, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis
por: Ames, Paul R.J., et al.
Publicado: (2020)

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2020)

Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis
por: Shaikh, Fahad, et al.
Publicado: (2021)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
por: Reda, Sara, et al.
Publicado: (2022)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2022)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition
por: Shi, Maojing, et al.
Publicado: (2022)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Effects of oral anticoagulant therapy in patients with pulmonary diseases
por: Lai, Jiying, et al.
Publicado: (2022)

Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study
por: Pratt, Nicole L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j4pvqac4aliae9easqacomklid